0001140361-16-078880.txt : 20160906 0001140361-16-078880.hdr.sgml : 20160906 20160906115510 ACCESSION NUMBER: 0001140361-16-078880 CONFORMED SUBMISSION TYPE: SC 13D PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20160906 DATE AS OF CHANGE: 20160906 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Cabinet Grow, Inc. CENTRAL INDEX KEY: 0001610462 STANDARD INDUSTRIAL CLASSIFICATION: AGRICULTURE PRODUCTION - CROPS [0100] IRS NUMBER: 465546647 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D SEC ACT: 1934 Act SEC FILE NUMBER: 005-89542 FILM NUMBER: 161870272 BUSINESS ADDRESS: STREET 1: 319 CLEMATIS STREET STREET 2: SUITE 812 CITY: WEST PALM BEACH STATE: FL ZIP: 33401 BUSINESS PHONE: 561-249-6511 MAIL ADDRESS: STREET 1: 319 CLEMATIS STREET STREET 2: SUITE 812 CITY: WEST PALM BEACH STATE: FL ZIP: 33401 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Dove Foundation CENTRAL INDEX KEY: 0001493379 IRS NUMBER: 376459117 STATE OF INCORPORATION: IL FILING VALUES: FORM TYPE: SC 13D BUSINESS ADDRESS: STREET 1: 5812 S. HOMAN AVE. CITY: CHICAGO STATE: IL ZIP: 60629 BUSINESS PHONE: 773-297-0018 MAIL ADDRESS: STREET 1: 5812 S. HOMAN AVE. CITY: CHICAGO STATE: IL ZIP: 60629 SC 13D 1 doc1.htm NONE Schedule 13D


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549



SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. n/a )*

Cabinet Grow, Inc.

(Name of Issuer)


Common Stock, Par Value $0.001

(Title of Class of Securities)


12682L103

(CUSIP Number)


James M. Delahunt, Esq.,  The Dove Foundation  4783 Lake Valley Drive Suite 2A  Lisle,  Illinois  60532  Phone : 773-297-0018

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)


August 16, 2016

(Date of Event which Requires Filing of this Statement)



If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.    o

Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See §240.13d-7 for other parties to whom copies are to be sent.

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
 


1
NAMES OF REPORTING PERSONS
   
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
   
The Dove Foundation
37-6459117
   
   
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)
o
 
(b)
o
   
3
SEC USE ONLY
   
     
   
4
SOURCE OF FUNDS
   
OO
   
   
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(e) or 2(f)
 
o
 
   
   
6
CITIZENSHIP OR PLACE OF ORGANIZATION
   
USA
   
   
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
7
SOLE VOTING POWER
   
262,944,662*
   
   
8
SHARED VOTING POWER
   
 
   
   
9
SOLE DISPOSITIVE POWER
   
262,944,662*
   
   
10
SHARED DISPOSITIVE POWER
   
 
   
   
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
   
262,944,662*
   
   
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
 
o
 
   
   
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
   
87.65 **%
   
   
14
TYPE OF REPORTING PERSON
   
OO
   
   
 
* 262,944,662 shares issued to the reporting person on August 16, 2016.

** Based on 300,000,000 outstanding shares as of August 16, 2016. Prior to the 262,944,662 share issuance, 37,055,338 shares were outstanding as of July 22, 2016.
 
 
 
Item 1.
Security and Issuer
  
 
 
This statement relates to the Common Stock, par value $0.001 (the “Shares”), issued by Cabinet Grow, Inc. (the “Issuer”). The address of the principal executive offices of the Issuer is 17932 Sky Park Circle, Suite F
Irvine, CA 92614.
 
Item 2.
Identity and Background
  
 
 
(a)
The Dove Foundation

 
(b)
4783 Lake Valley Drive
Suite 2A
Lisle, Illinois 60532

 
(c)
N/A

 
(d)
N/A

 
(e)
N/A

 
(f)
USA
 
Item 3.
Source and Amount of Funds or Other Consideration
  
 
 
Chicago Venture Partners, LP ("CVP") purchased the Secured Convertible Promissory Note (the "Note") from Cabinet Grow, Inc. on June 6, 2014. On April 29, 2016, CVP assigned the Note to the Reporting Person according to the Assignment and Assumption Agreement. The aggregate purchase price of the Shares purchased by the Reporting Person was $250,000. The Reporting Person holds, in the aggregate, 262,944,662 Shares. There were no commissions paid.
 
Item 4.
Purpose of Transaction
  
 
The Reporting Person purchased the Shares for investment purposes.

 
(a)

 
(b)

 
(c)

 
(d)

 
(e)

 
(f)

 
(g)

 
(h)

 
(i)

 
(j)
 
Item 5.
Interest in Securities of the Issuer
  
 
(a)
The Reporting Person may be deemed to beneficially own, in the aggregate, 262,944,662 shares, representing approximately 87.65% of the Issuer’s outstanding shares, based upon 300,000,000 shares outstanding as of August 16, 2016.

 
(b)
The reporting person has sole voting power and sole dispositive power with regard to 262,944,662 shares of Common Stock.

 
(c)

 
 
Transaction Date Shares or Units Purchased (Sold) Price Per Share or Unit 
 
 

 
 
 

 
 

 
(d)

 
(e)
 
Item 6.
Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer
  
 
 
 
Item 7.
Material to Be Filed as Exhibits
  
 
 
1.Secured Convertible Promissory Note made by the Issuer in favor of CVP dated June 6, 2014.
 

Signature
 
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 
The Dove Foundation
 
       
September 06, 2016
By:
/s/ James M. Delahunt
 
   
Trustee
 
       
 
The original statement shall be signed by each person on whose behalf the statement is filed or his authorized representative. If the statement is signed on behalf of a person by his authorized representative (other than an executive officer or general partner of the filing person), evidence of the representative’s authority to sign on behalf of such person shall be filed with the statement: provided, however, that a power of attorney for this purpose which is already on file with the Commission may be incorporated by reference. The name and any title of each person who signs the statement shall be typed or printed beneath his signature.

Footnotes: 
 
Attention: Intentional misstatements or omissions of fact constitute Federal criminal violations (See 18 U.S.C. 1001)
 
 


EX-1 2 misc1.htm EX-1
 
Exhibit 1

NEITHER THIS PROMISSORY NOTE NOR ANY OF THE SECURITIES ISSUABLE HEREUNDER HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "ACT") OR ANY STATE SECURITIES LAWS, AND MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF A REGISTRATION STATEMENT IN EFFECT WITH RESPECT TO THE SECURITIES, OR DELIVERY TO THE COMPANY OF AN OPINION OF COUNSEL IN FORM AND SUBSTANCE SATISFACTORY TO THE COMPANY THAT SUCH OFFER, SALE OR TRANSFER, PLEDGE OR HYPOTHECATION IS IN COMPLIANCE WITH THE ACT OR UNLESS SOLD IN FULL COMPLIANCE WITH RULE 144 UNDER THE ACT.
UNITED AMERICAN HEALTHCARE CORPORATION
UNSECURED PROMISSORY NOTE
$50,000 October 10, 2012
United American Healthcare Corporation, a Michigan corporation (the "Company"), for value received, hereby promises to pay to St George Investments LLC, an Illinois limited liability company, or its assignee (the "Holder"), the principal amount of Fifty Thousand Dollars Exactly ($50,000.00) (such amount is referred to herein as the "Principal Amount"), together with simple interest on the unpaid amount thereof at ten percent (10.0%) per annum, computed on the basis of a 365-day year for the actual number of days elapsed from the date hereof until paid or converted in accordance with the terms hereof.
This Note is issued pursuant to the terms and conditions set forth in that certain Note Purchase Agreement between the Company and the Holder of even date herewith (the "Purchase Agreement").
1.            Promissory Note (this "Note")
1.1            Payment.  The Principal Amount plus all accrued but unpaid interest thereon shall become due and payable on the date (the "Due Date") that is the earlier of (a) December 31, 2014, or (b) the date of (i) the sale of all or substantially all of the assets of the Company or Pulse Systems, LLC, (ii) the merger of the Company or Pulse Systems, LLC, or (iii) the sale of all or substantially all of the equity of the Company or Pulse Systems, LLC (collectively, a "Company Sale").  Provided that no Event of Default (as defined in Section 4) has occurred, the Company shall not be required to make any payments on this Note prior to the Due Date.  For purposes of this Note, a "business day" shall mean any day which is not a Saturday, Sunday, or a day on which commercial banks in Chicago, Illinois are required or permitted by law to be closed.
1.2            Payment Mode.  Payment of this Note shall be made by the Company to the Holder in U.S. Dollars in immediately available funds at the address of the Holder as set forth in the Company's records or as otherwise directed by the Holder, unless this Note is converted upon an Event of Default into shares of the Company's common stock ("Common Stock") pursuant to Section 5 at the sole election of the Holder.
1.3            Application of Payments.  Payments on this Note shall be applied first to accrued interest, and thereafter to the outstanding principal balance hereof.  Any and all payments by the Company to the Holder hereunder shall be made free and clear of, and without deducting or withholding for, any taxes, levies, assessments, imposes, duties, fees or similar charges, except where the Company is required by law to make such deduction or withholding.
1.4            Waiver of Presentment.  The Company waives presentment for payment, demand, protest and notice of protest for nonpayment of this Note, and consents to any extension or postponement of the time of payment or any other indulgence.
2.            Authorized Shares.  As collateral security for this Note, the Company shall maintain in reserve a sufficient number of authorized but unissued shares of Common Stock for the Company to issue to the Holder all of the shares of Common Stock that would be issuable upon conversion of all of the Principal Amount and the accrued but unpaid interest thereon upon an Event of Default pursuant to Section 5 (such number, a "Sufficient Number of Authorized Shares").  The Company shall take all necessary and desirable action to further amend its Amended and Restated Articles of Incorporation to increase the number of authorized but unissued shares of Common Stock, as may be necessary from time to time, in order to maintain a Sufficient Number of Authorized Shares.  If such amendment is not made within four (4) full calendar months after the time at which the Company first does not have a Sufficient Number of Authorized Shares, then the Principal Amount shall increase, by two percent (2%) of the sum of (a) the Principal Amount and (b) the amount of unpaid monthly interest thereon, each full month until such amendment is made and the Company again has a Sufficient Number of Authorized Shares.
3.            Right of First Offer; Right of First Refusal.  The Company shall not solicit any equity investment, loan, or other financing without first requesting in writing that the Holder propose such financing ("First Offer").  The Company shall send a written notice to the Holder requesting a First Offer, and then the Holder shall have thirty (30) days to respond.  If the Holder responds with a written financing offer, the Board of Directors of the Company shall negotiate in good faith with the Holder for a period of an additional thirty (30) days in order to reach an agreement on terms.  If the parties are able to reach an agreement, the financing shall be consummated within thirty (30) days after the agreement is reached.  If the parties are unable to reach agreement, or if the Holder declines to offer financing or does not respond in a timely manner, then the Company shall be free to solicit financing proposals from third parties.  However, if a third party presents a "credible financing proposal" (as defined in the next sentence) to the Company (the "Third-Party Proposal"), the Board shall inform the Holder in writing within five (5) days after the Company's receipt of the proposal, and the Holder shall then have thirty (30) days thereafter to consummate a financing on the same terms and conditions as in the Third-Party Proposal.  A "credible financing proposal" is one in which the financing source has provided the Company with written assurances of its ability and willingness to consummate the proposed financing within thirty (30) days.  If the Holder declines to provide financing on the same terms and conditions as in the Third-Party Proposal, and if the financing source fails to consummate the financing within thirty (30) days of the date of its proposal, then the Company shall consummate the financing proposed by the Holder, if any was proposed, within thirty (30) days after the financing contemplated by the Third-Party Proposal was scheduled to occur, and the Company shall pay to the Holder a fee of $100,000 to compensate for the delay and expense.
4.            Events of Default.  The Holder may declare all or a portion of the Principal Amount and accrued but unpaid interest thereon immediately due and payable, effective upon written notice to the Company, upon the occurrence of any of the following events occurs (each, an "Event of Default"):
(a)            The Company defaults in the payment of this Note, whether the Principal Amount or the interest thereon, when due;
(b)            The Company:
(i)            Commences any proceeding or any other action relating to it in bankruptcy or seeks reorganization, arrangement, readjustment of its debts, dissolution, liquidation, winding-up, composition or any other relief under the United States Bankruptcy Act, as amended, or under any other insolvency, reorganization, liquidation, dissolution, arrangement, composition, readjustment of debt or any other similar act or law, of any jurisdiction, domestic or foreign, now or hereafter existing;
(ii)            Admits its inability to pay its debts as they mature in any petition or pleading in connection with any such proceeding;
(iii)            Applies for, or consents to or acquiesces in, an appointment of a receiver, conservator, trustee or similar officer for it or for all or substantially all of its assets and properties;
(iv)            Makes a general assignment for the benefit of creditors; or
(v)            Admits in writing its inability to pay its debts as they mature;
(c)            Any proceeding is commenced or any other action is taken against the Company in bankruptcy or seeking reorganization, arrangement, readjustment of its debts, dissolution, liquidation, winding-up, composition or any other relief under the United States Bankruptcy Act, as amended, or under any other insolvency, reorganization, liquidation, dissolution, arrangement, composition, readjustment of debt or any other similar act or law, of any jurisdiction, domestic or foreign, now or hereafter existing; or a receiver, conservator, trustee or similar officer for the Company or for all or substantially all of its assets and properties is appointed; and in each such case, such event continues for ninety (90) days undismissed, unbonded and non-discharged;
(d)            The Company (or any wholly owned subsidiary of the Company) materially breaches (or fails to cure any continuing breach for a period of more than 30 days) any obligation set forth in (i) this Note, (ii) the Purchase Agreement or any of the other Transaction Documents (as defined in the Purchase Agreement), (iii) the Security Agreement (defined below), (iv) any other agreement between the Company (or any wholly owned subsidiary of the Company) and the Holder, or (v) any material agreement, including but not limited to any loan agreement, between the Company (or any wholly owned subsidiary of the Company) and any other party;
(e)            A "change in ownership" (as defined in Section 382 of the Internal Revenue Code) occurs; or
(f)            The Company fails, within four (4) full calendar months after the time at which the Company does not have a Sufficient Number of Authorized Shares, to further amend its Amended and Restated Articles of Incorporation to increase the number of authorized but unissued shares of Common Stock in an amount necessary to maintain a Sufficient Number of Authorized Shares, as provided in Section 2.
Upon the occurrence and continuation of an Event of Default, regardless of whether the Holder declares the Principal Amount and accrued but unpaid interest thereon to be immediately due and payable, interest on this Note will increase to an annual rate of eighteen percent (18%) from the date the Event of Default first occurred until the earlier of the dates on which (i) the Event of Default is cured to the sole reasonable satisfaction of the Holder, (ii) all outstanding principal and interest on this Note is paid in full, or (iii) this Note is converted upon an Event of Default pursuant to Section 5 at the sole election of the Holder.
Conversion Upon the Occurrence of an Event of Default.  Upon the occurrence and continuation of an Event of Default, at any time and from time to time until the repayment in full of the Principal Amount and all accrued but unpaid interest thereon to the Holder, the Holder may, in its sole discretion and as a remedy, convert all or part of the Principal Amount and the accrued but unpaid interest thereon into newly issued shares of Common Stock.  Subject to adjustment pursuant to the next paragraph, the conversion price is $0.004323 per share of the Common Stock, which conversion price is based on one hundred ten percent (110%) of the average of the closing bid prices for the Common Stock on the Thirty (30) trading days ending October 10, 2012, which is the date on which the Company's Board of Directors adopted resolutions approving the terms of this Note and the transactions contemplated hereby.  The Holder may exercise this conversion remedy by providing the Company with written notice of the Holder's intent to convert and of the amount of the Principal Amount and accrued interest thereon subject to conversion.  The conversion shall then occur on the next business day following the date of the notice.  The Company agrees that the Common Stock reserved for issuance upon conversion is a pledge and a security interest in collateral for the benefit of the Holder.
If, at any time and from time to time while any amount is owed by the Company on this Note, the Company issues equity (or debt or other instruments convertible into equity) at a price per share of Common Stock or Common Stock equivalent (or with a conversion price per share of Common Stock or Common Stock equivalent) lower than the conversion price set forth in the previous paragraph, then the conversion price set forth in the previous paragraph shall be reduced to such lower price, regardless of whether the Company subsequently issues equity (or debt or other instruments convertible into equity) at a price per share of Common Stock or Common Stock equivalent (or with a conversion price per share of Common Stock or Common Stock equivalent) higher than the conversion price set forth in the previous paragraph.
Notwithstanding anything to the contrary in this Note, no conversion of all or part of the Principal Amount and the accrued but unpaid interest thereon into Common Stock shall be permitted if such conversion would cause an "ownership change" as defined in Section 382 of the Internal Revenue Code; provided, however, that the foregoing shall not apply if such an "ownership change" has occurred at any time prior to such conversion.
5.            Security.  This Note is secured by that certain Security Agreement dated August 14, 2012, as the same may be amended from time to time, executed by the Company in favor of the Holder encumbering all of the assets of the Company (the "Security Agreement"), all the terms and conditions of which are hereby incorporated into and made a part of this Note.  This Note is also secured by that certain Pledge and Security Agreement dated August 14, 2012, as the same may be amended from time to time, executed by the Company in favor of the Holder pledging as collateral for repayment of this Note the membership units held by the Company in Pulse Systems, LLC, a Delaware limited liability company (the "Pledge Agreement"), all the terms and conditions of which are hereby incorporated into and made a part of this Note.  Upon the occurrence of an Event of Default, the Holder may pursue all of its rights and remedies at law or in equity, including without limitation, foreclosure upon the collateral described in Security Agreement and the Pledge Agreement.
6.            Miscellaneous.
6.1            Transfer of Note, Etc.  This Note is transferable and assignable by the Holder, subject to the requirement that any such assignment or transfer be, in the reasonable opinion of the counsel of the Holder, in full compliance with applicable state and federal securities laws; provided that no such opinion of counsel shall be necessary for a transfer by the Holder to an affiliated entity or to a stockholder, member or partner of the Holder, or transfers by gift, will or intestate succession to any spouse or lineal descendants or ancestors, if all transferees agree in writing to be subject to the terms hereof to the same extent as if they were the original Holder hereof.  All covenants, agreements and undertakings in this Note by or on behalf of any of the parties shall bind and inure to the benefit of the respective successors and assigns of the parties whether so expressed or not.  This Note may not be assigned by the Company without the written consent of the Holder.
6.2            Attorneys' Fees.  In the event of any dispute between the parties hereto in connection with this Note, the prevailing party shall be entitled to recover from the losing party all of its costs and expenses, including, without limitation, court costs and reasonable attorneys' fees.
6.3            Amendments and Waivers.  The right to the payment of the Principal Amount and all accrued but unpaid interest thereon, and any provision of this Note, may be amended or waived only with the written consent of the Holder, which consent may be withheld for any reason.  Any amendment effected in accordance with this Section 6.3 shall be binding upon any Holder of this Note (and of any securities into which this Note is convertible), each future holder of all such securities, and the Company, even if such Holder of this Note or such future holder has not executed such amendment.  This Note may not be prepaid in full or in part prior to the Due Date.
6.4            Severability.  If one or more provisions of this Note are held to be unenforceable under applicable law, such provision shall be excluded from this Note and the balance of the Note shall be interpreted as if such provision were so excluded and shall be enforceable in accordance with its terms.
6.5            Governing Law.  This Note shall be governed by and construed and enforced in accordance with the laws of the State of Illinois, without giving effect to its conflicts of laws principles.
[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]


Date:  October 10, 2012
UNITED AMERICAN HEALTHCARE CORPORATION, a Michigan corporation


By:            /s/ Robert T. Sullivan
Name:            Robert T. Sullivan
Title:            Chief Financial Officer


ACKNOWLEDGED AND AGREED:
ST GEORGE INVESTMENTS LLC,
an Illinois limited liability company

By:            Fife Trading, Inc.
an Illinois corporation,
its Manager

By:            /s/ John M. Fife
Name:            John M. Fife
Title:            President